A detailed history of Lebenthal Global Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 20,483 shares of BSX stock, worth $1.84 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
20,483
Previous 18,838 8.73%
Holding current value
$1.84 Million
Previous $1.45 Million 18.34%
% of portfolio
0.35%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$72.96 - $84.0 $120,019 - $138,180
1,645 Added 8.73%
20,483 $1.72 Million
Q2 2024

Jul 24, 2024

BUY
$67.33 - $77.71 $19,391 - $22,380
288 Added 1.55%
18,838 $1.45 Million
Q1 2024

May 09, 2024

BUY
$57.6 - $68.62 $95,270 - $113,497
1,654 Added 9.79%
18,550 $1.27 Million
Q4 2023

Feb 07, 2024

BUY
$48.64 - $57.81 $821,821 - $976,757
16,896 New
16,896 $976,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Lebenthal Global Advisors, LLC Portfolio

Follow Lebenthal Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.